Scientists and mental health researchers have long been collecting evidence to discover what causes depression. Their goal is to find a specific neurotransmitter or system that could be targeted to develop a new class of antidepressant medication that would be more effective for the masses, result in less side effects, and be considered safe. While …
Ketamine is a drug that is used to induce sedation in humans in a controlled environment. It is also used recreationally and is referred to as “Special K.” Ketamine is an NMDA antagonist that functions as a sedative, analgesic, and has therapeutic properties when used with an anesthetic. In regards to recreational usage, Ketamine has …
Lanicemine (AZD6765) is an NMDA antagonist developed by the company AstraZeneca in hopes to help people with treatment-resistant depression. Let’s face it, if you have treatment-resistant depression, you are probably waiting for some sort of breakthrough in technology and/or a new class of drugs for treatment. Although many people find benefit from SSRI’s, TCA’s, and …